Jolly et al.,66 explained that SeNPs' anticancer properties are attributed to selenium's activation of glutathione S-transferase (GST) hence inhibiting cancer cell development by causing cell cycle arrest at the S phase. The gene discussed is HPGDS; the disease is cancer.